1 Day VERX 0.96% DJIA -0.75% S&P 500 -0.50% Business/Consumer Services -1.53% ...

Journavx received FDA approval, the agency announced on Thursday, Jan. 30. The drug developed by Boston-based Vertex Pharmaceuticals blocks sodium channels in the peripheral nervous system, preventing ...

The company’s shares closed yesterday at $438.40. Harrison covers the Healthcare sector, focusing on stocks such as Vertex Pharmaceuticals, BridgeBio Pharma, and Keros Therapeutics. According to ...

A duvet cover not only protects your comforter, it also adds a design element to your bedscape. Even if you’re conservative in your choice of bed sheets — crisp, white percale sheets, ...

Wells Fargo analyst Mohit Bansal downgraded Vertex Pharmaceuticals (VRTX) to Equal Weight from Overweight with an unchanged price target of $460. Published first on TheFly – the ultimate source ...

Vertex Pharmaceuticals (VRTX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance ...

Vertex Pharmaceuticals (VRTX) is one of the stocks most watched by Zacks.com visitors lately. So, it might be a good idea to review some of the factors that might affect the near-term performance of ...

1 Day VERX 0.61% DJIA 0.65% S&P 500 -1.46% Business/Consumer Services 1.34% ...

Sir Keir Starmer was accused of being part of a “cover-up” of the truth about the Southport murderer as he prepared to address the nation over the state’s failure to stop the attack.